Skip to main content

Compounded Topical Pain Creams Review of Select Ingredients for Safety, Effectiveness, and Use (2020) / Chapter Skim
Currently Skimming:

Appendix A: Study Approach
Pages 241-246

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 241...
... , the National Academies of Sciences, Engineering, and Medicine's Committee on the Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredients Used in Compounded Topical Pain Creams was charged with identifying and analyzing the available scientific data relating to the ingredients used in compounded topical pain creams and evaluating how these data translate to the safety and effectiveness of compounded topical pain creams with various combinations of those ingredients. The committee's final report will summarize the current evidence on compounded topical pain creams and offer recommendations on their use.
Read the entire page →
From page 242...
... These resources include, but are not limited to, data on active pharmaceutical ingredients commonly used in compounded topical pain creams, literature reviews, findings from national surveys related to the cost and use of compounded topical pain creams, adverse event reports, and guidance on the federal and state regulations and oversight for compounded preparations. First Committee Meeting Open Session Agenda March 25, 2019 National Academies Keck Building 500 Fifth Street, NW, Washington, DC 20001 1:15 p.m.
Read the entire page →
From page 243...
... Edward Norton, MSC, USN, Pharmacy Specialty Leader Defense Health Headquarters Timothy McPherson, Professor Department of Pharmaceutical Sciences Southern Illinois University, Edwardsville Jeffery Fudin, Clinical Pharmacy Specialist and Director [Remote] PGY-2 Pharmacy Pain Residency Programs Stratton Veterans Affairs Medical Center 4:30 p.m.
Read the entire page →
From page 244...
... U.S. Food and Drug Administration Gregg Jones, R.Ph.
Read the entire page →
From page 245...
... ADJOURN Fourth Committee Meeting Open Session Agenda October 1, 2019 National Academies Keck Building 500 Fifth Street, NW, Washington, DC 20001 12:30 p.m. Welcome Debra A
Read the entire page →
From page 246...
... J Day, Pharm.D., Vice President of Clinical Services, P ­ rofessional Compounding Centers of America 1:30 p.m.
Read the entire page →

Key Terms

  • compounded topical
  • pain creams
  • compounding centers
  • professional compounding
  • available scientific

  • american chronic
  • pain association
  • chronic pain
  • committee chair
  • pain management

  • pharmacy specialty
  • public comments
  • additional relevant
  • relevant information
  • active pharmaceutical

  • texas physician
  • current evidence
  • residency programs
  • veterans affairs
  • session workshop

  • clinical pharmacy
  • mittee included
  • committee expertise
  • included periods
  • data translate

  • offer recommendations
  • jeffery fudin
  • clinical nurse
  • collection efforts
  • event reports


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.